Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
53
天
Overall Survival After Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Patients With Three Recorded Positive Nodes: A National Cancer Database Analysis
作者
Kai Huang; Emmanuel Gabriel展开收起
作者单位
Department of Surgery, Prevea Health, St. Vincent Regional Cancer Center, Green Bay , WI; Department of Surgery, Mayo Clinic Florida, Jacksonville, FL展开收起
89
天
CTSG Suppresses Breast Cancer Progression by Inhibiting the EGFR/ERK Signaling Pathway and Enhancing CD8⁺ T Cell Activation
作者
Yue Pan; Chenhui Zheng; Danni Zheng; Yin Pan展开收起
作者单位
Department of Surgical Oncology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China展开收起
296
天
Cost-effectiveness of Biennial Breast Screening in Women With Dense Breasts: Exploratory Analysis of Pathways Incorporating an Emerging Blood RNA Test
作者
Jacie T. Cooper; Alan Hollingsworth; Randy D. Moore; Cheryl Croft; John Schneider; Kristina D. Rinker; Eldon Spackman展开收起
作者单位
Avalon Health Economics, Miami, FL; Syantra Inc., Calgary, AB, Canada; Croft Healthcare Consulting LLC, Jacksonville, FL; Department of Biomedical Engineering and Department of Physiology and Pharmacology, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada; Department of Surgery, University of Calgary, Calgary, AB, Canada展开收起
117
天
Epigenetic Remodeling Through GSK343-induced EZH2 Inhibition Alters SMYD2/SMYD3 Expression and Promotes Antitumor Effects
作者
Thaís Amanda Damasceno Silva; Eduardo Vignoto Fernandes; Mayara Bocchi; Fermino Sanches Lizarte Neto; Fábio Morato de Oliveira展开收起
作者单位
Laboratory of Human and Medical Genetics, Federal University of Jataí, Jataí-GO, Brazil; Laboratory of Immunometabolism, Nutrition, and Exercise (LABINE), Federal University of Jataí, Jataí-GO, Brazil; Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天